TGFB1 and neoplasm: In the later stages of cancer, when tumor cells have acquired oncogenic mutations and/or have lost gene suppressor function and have become resistant to TGF-β-induced growth arrest, this cytokine leads to tumor promotion by inducing epithelial–mesenchymal transition (EMT) [111,112].